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long periods.[1,4] Outbreaks of BCC septicaemia have been 
documented worldwide in intensive care units (ICUs), 
oncology units and renal failure patients.[5,6] The incidence 
of disease due to these NFGNBs seems to be increasing. 
S. maltophilia is the third most common pathogenic NFGNB 
worldwide after Pseudomonas aeruginosa and Acinetobacter 
calcoaceticus-baumannii complex.[7,8]
BCC and S. maltophilia are exclusive members of 
the medically important lysine decarboxylase-positive 
NFGNB group (henceforth mentioned as lysine-positive 
NFGNBs).[7] It has always been a tedious task for a routine 
microbiological laboratory to identify the NFGNBs and 
poor laboratory proficiency in identification of these 
NFGNBs prevails worldwide, including in our own country. 
For this reason, reports of disease due to these organisms 
are rare from India.[2] Identification through commercial 
kits and automated systems is not fool-proof as many non-
Burkholderia betaproteobacteria (Ralstonia picketti and 
Pandoraea species) are labelled as BCC and some BCC 
strains as Pseudomonas aeruginosa.[9]
Inherent in these lysine-positive NFGNBs is a contrasting 
susceptibility pattern to that of P. aeruginosa. These 
pathogens are among the most antimicrobial-resistant 
bacteria. BCC is intrinsically resistant to aminoglycosides and 
polymyxins and often develops resistance to β-lactams due 
to the presence of inducible chromosomal β-lactamases and 
altered penicillin-binding proteins.[8] Antibiotic efflux pumps 
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The Burkholderia cepacia complex (BCC) and 
Stenotrophomonas maltophilia are a closely related group of 
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many niches of both natural and clinical environments. Both 
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to deep-seated and disseminated infections. BCC, a devastating 
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and septicemia in non-CF patients.[1,2] Its classification has 
undergone considerable taxonomic changes over the last 
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BCC has emerged as an important cause of morbidity and 
mortality in hospitalized patients largely because of the high 
intrinsic antibiotic resistance. BCC survives and multiplies 
in aqueous hospital environments where it may persist for 
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in BCC mediate resistance to chloramphenicol, trimethoprim 
and fluoroquinolones. S. maltophilia is intrinsically resistant 
to most β-lactams, including carbapenems, the group 
commonly used in Pseudomonas infections.[8,9]
An upsurge of septicaemia due to NFGNBs was 
documented in our institute in 2004. Hence, we started 
identifying NFGNBs to the species level. About half of 
these (41%) strains in 2005 were lysine-positive BCC and 
S. maltophilia. We present the results of our investigation, 
some simple methods for identification and maintenance of 
these microorganisms and their antimicrobial susceptibility 
results. The most important area of our work is on BCC, 
which includes molecular identification and typing too. 
Therefore, more details are available for BCC below.
The aim of this paper is to help routine diagnostic 
bacteriology laboratories to identify lysine-positive 
NFGNBs using only five tubes of conventional biochemical 
reactions with the available infrastructure and resources.
Materials and Methods
Bacterial isolates
Bacterial culture was carried out in the clinical 
bacteriology laboratory of the Department of Medical 
Microbiology as a part of routine diagnostic services to the 
patients admitted in the hospital. The clinical isolates were 
identified by conventional biochemical tests. Gram-negative, 
motile, NFGNB were identified by the use of oxidase test, lead 
acetate paper strip for H2S production, lysine decarboxylase, 
ornithine decarboxylase and arginine dihydrolase and aerobic 
low peptone (ALP) medium slants (containing ammonium 
salts incorporated with glucose) [Table 1].
Among BCC isolates, representative strains in the beginning 
were confirmed by the International B. cepacia Working Group 
at Belgium. BCC isolates were lyophilized and stored at 4ºC 
for further reference. The identification of isolates as members 
of the BCC was confirmed by a triphasic analysis:
1. Conventional biochemical testing system [Table 1] 
followed by
2. recA polymerase chain reaction (PCR)-based 
Identification.
 Molecular identification by PCR assays was based 
on the recA gene.[10] Three or four colonies of 
bacteria were taken from growth on nutrient agar 
plates and resuspended in Tris-ethylene diammine 
tetraacetate (EDTA) buffer. Genomic DNA was 
isolated using the Avegene system as per the protocol 
recommended by the supplier (Avegene, Taiwan). 
DNA was quantitated spectrophotometrically 
and approximately 20 ng was incorporated into 
25-mL reactions containing 1 U Taq DNA polymerase, 
250 µM (each) deoxynucleoside triphosphate, 1.5 µM 
MgCl2 and 1X PCR buffer. Approximately 20 pmol of 
each appropriate oligonucleotide primer was added to 
each reaction and amplification was carried out using 
a thermal cycler for 30 cycles of 30 s at 94°C, 45 s 
at the appropriate annealing temperature and 60 s at 
72°C. A final extension of 10 min at 72°C was applied 
to all thermal cycles. To avoid the non-specific bands, 
dimethylsulphoxide and formamide were added in 
concentrations of 0.25 µL/reaction and 0.32 µL/reaction 
in the 25-µL reaction mix. PCR products were analysed 
by agarose gel electrophoresis (1.5%) using 1X Tris-
EDTA buffer. Molecular size markers of the appropriate 
size range were included on all gels (100-bp DNA ladder).
3. Restriction fragment length polymorphism (RFLP) 
analysis for species identification.
 Species designation using RFLP of the recA PCR 
products further confirmed the identity of the strains.[10]
 To identify BCC isolates at the species level, RFLP 
analysis was performed. For RFLP analysis, 10 µL of 
the PCR product was combined with the appropriate 
restriction enzyme buffer (5 µL) and 1 µL endonuclease 
(BsuRI) as outlined by the manufacturer (Fermentas, 
Canada) and incubated at 37°C for 1h. RFLP products 
were analysed by agarose gel electrophoresis (2.5%) 
using 1X Tris-EDTA buffer. Molecular size markers of 
the appropriate size range were included on all gels (100-
bp DNA ladder or 1-kb DNA ladder; 50-bp ladder).[10]
 During the course of our experience, the medium base 
for oxidation-fermentation studies was changed from 
the classical Hugh and Leifson base to the ammonium 
phosphate-based ALP medium (Pickett, 1989). It was 
observed that acidification frequently occurred more 
Table 1: Simplified identification table for lysine-positive non-fermenting gram-negative bacilli
Lysine-positive NFGNBs Oxidase Smell TSI H2S (lead 
acetate strip)
L O A ALP (Glu)
Burkholderia cepacia 
complex
P Dirt-like K/K* N P1 P2 N P3
Stenotrophomonas 
maltophilia
N Ammoniacal 
odour**
K/K P P N N N
ALP aerobic low peptone medium; L, O, A lysine decarboxylase, ornithine decarboxylase, arginine dihydrolase;[1], may be lysine 
negative;[2], may be ornithine negative;[3], if glucose is not oxidatively utilized among the B. cepacia complex, then it can be labelled as
B. cenocepacia. All the species oxidize glucose (100%) while 4% B. cenocepacia isolates do not utilize it,[8]; *Many strains produce a 
bright yellow pigment (a very useful indicator) [Figure 3]; **As per our experience, ammoniacal odour is not present in all the strains.
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quickly in the ALP medium [Figure 1] than in the Hugh 
and Leifson sugars and no alkalinity that could mask 
the weakly acidic sugars, as can sometimes occur with 
Hugh and Leifson sugars, was observed.[11]
Antimicrobial susceptibility
Antimicrobial susceptibility testing was performed by 
the Kirby-Bauer disc diffusion method as per the Clinical 
Laboratory Standards Institute (CLSI), 2007 guidelines 
against co-trimoxazole, meropenem, ceftazidime, tetracycline 
and levofloxacin (control strains were Escherichia coli ATCC 
25922 and Pseudomonas aeruginosa ATCC 27853).[12] The 
piperacillin-tazobactam combination had also been tested.
Minimum inhibitory concentration (MIC)
For BCC isolates, MICs were performed by the agar and 
broth dilution methods against ceftazidime and tetracycline 
(control strains were Escherichia coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853).[12]
Short-term maintenance of cultures
Few colonies of BCC were passed in Robertson’s cooked 
meat medium (RCM) without paraffin and incubated at 35°C 
overnight. The RCM was then kept at 4°C. Isolates retained 
their viability for a minimum of 2 weeks.
Preservation
Brain heart infusion broth with 10% glycerol was used 
for preserving BCC. Two loopfuls (one can add more) of 
pure culture were added to vials containing 1 mL of the 
stocking media and kept at −20°C. When reviving, the stock 
vials were kept at 37°C for half an hour and subcultured 
after overnight incubation in nutrient broth or peptone water 
onto a blood agar plate. If unsuccessful, the growth from the 
stock medium was inoculated into tryptone soy broth and 
then subcultured on to blood agar or MacConkey agar after 
overnight incubation. Lyophilization was performed as per 
textbook recommendations.[8] The chamber or batch method 
was used, skim milk was used as the cryopreservative and a 
very high initial inoculum of 1010 cfu/mL (recommended by 
Heckley) was used. The glass vials were stored at −20°C, as 
recommended.[8] While reconstituting, the vial surfaces were 
cleaned with 70% alcohol and both RCM broth and blood 
agar media were inoculated. A purity check was carried 
out for each isolate to rule out cross contamination. All 
reconstitution and preservation techniques were performed 
under sterile precautions in a Biosafety cabinet IIA.
Results
Of the 1235 positive blood cultures during 3 months 
(November 2004-January 2005), 170 (13.7%) were NFGNBs. 
Among these, 70 (41.2%) strains were identified as lysine-
positive NFGNBs (BCC and S. maltophilia) and others were 
identified as Alcaligenes spp. (40, 23.5%), P. aeruginosa 
(31, 18.2%), Chryseobacterium indologenes (1, 0.6%) and 
Brevundimonas diminuta (1, 0.6%), respectively. Twenty-
seven (16%) strains could not be identified by the limited 
available conventional biochemical tests. In 2005 (September-
December), of the 7779 blood cultures, 74 (29.1%) lysine-
positive NFGNBs were obtained out of 254 NFGNBs.
In 2006-2007 (September-December) of the 8601 blood 
cultures, we isolated 25 (11.36%) lysine-positive NFGNBs 
among 220 NFGNBs. Lysine-positive NFGNBs were 
also isolated from respiratory samples (bronchoalveolar 
lavage and sputum). Thirty isolates of BCC and 20 of S. 
maltophilia were obtained in the year 2006. Thirty-nine 
isolates of the BCC were obtained from various specimens 
(30 from blood cultures) and 22 S. maltophilia (13 blood 
cultures and 9 respiratory isolates) isolates were isolated 
during the year 2007 alone.
The results of the antimicrobial susceptibility testing by the 
disc diffusion method are given in Table 2. By MIC testing, 
80% BCC isolates (32/40) were sensitive to ceftazidime while 
82.5% strains were resistant to tetracycline (33/40).
Of the 41 isolates collected over the last 4 years and 
subjected to recA PCR-RFLP, 22 isolates were identified as 
B. cenocepacia IIIA (recA PCR-RFLP type G) [Figure 2], 
two were identified as B. cenocepacia IIIB (recA PCR-RFLP 
typeAN) and seven were identified as B. cepacia (recA PCR-
RFLP type E). In four isolates, no band was obtained and 
another four isolates revealed a faint band. A different base 
pair band was obtained in one isolate and one isolate among 
the five isolates of a single patient was lost.
Discussion
Identification of these organisms is tedious. We devised a 
simple algorithm for identification and preservation of these 
organisms in the laboratory. Over a span of 4 years, the 
number of biochemical reactions has been reduced from 16 
to just five and substantiated by the molecular identification. 
130 Indian Journal of Medical Microbiology vol. 27, No. 2
Figure 1: Aerobic low peptone (ALP) medium 1, G, glucose; 2, Xy, 
xylose; Bc, B. cepacia complex
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Further, the identification period has been shortened to just 
1 week from 1 month. With expertise, the identification 
can be performed the next day if biochemical reactions 
are properly inoculated. Further, one out of 10 known 
species (formerly, genomovar) of the genus Burkholderia 
can be labelled without molecular processing. However, 
on performing recA PCR, the isolates that do not yield a 
product of the right size, a double product, a faint product 
or a product with the wrong size are not considered BCC. 
Many laboratories are identifying the organisms by 
automated systems. However, when Burkholderia species 
are tentatively identified using an automated system, the 
identity of an isolate should be confirmed by conventional 
biochemical testing and, if necessary, molecular 
techniques.[8,13] We have encountered cases where S. 
maltophilia has been labelled as BCC (95% probability 
indicated by the system) and another system labelled BCC 
as B. pseudomallei (99% probability). One limitation of 
these conventional methods is that we are likely to miss 
lysine-negative BCC.
Thirty BCC isolates were identified by conventional 
methods in the year 2006 from blood cultures and 39 isolates 
of BCC isolates were obtained in the year 2007 from various 
specimens. In comparison, a study by Reik et al. isolated 
only 90 strains over a span of 8 years from various clinical 
specimens of non-CF patients.[14]
Of the 41 isolates collected over the last 4 years and 
subjected to recA PCR-RFLP, 31 isolates were identified 
as BCC. In four isolates, no band was obtained and another 
four isolates revealed a faint band. Although a faint band is 
taken as negative, in our experience, in one such strain, the 
RFLP pattern type G was obtained (B. cenocepacia, RFLP 
type IIIA). In one strain we obtained a sharp non-specific 
band and one isolate was lost. However, the sensitivities 
and specificities of such PCR assays for the intended 
target species are difficult to determine in the absence of a 
reliable “gold standard”.[8] Unidentified isolates have been 
present in previous epidemiological studies,[15] and it seems 
likely that the number of genospecies constituting the BCC 
complex may continue to rise.[3] In a recent Brazilian study 
also, 41 CF isolates of BCC were identified by culture and 
confirmation of identity and genomovar determination was 
obtained in 32 isolates by recA PCR.[15]
B. cenocepacia (earlier genomovar III) is further divided 
into at least four phylogenetic lineages (IIIA, IIIB, IIIC and 
IIID).[16] Of the 41 isolates subjected to recA PCR-RFLP, 22 
isolates were identified as B. cenocepacia IIIA (recA PCR-
RFLP type G) [Figure 2]. The importance of molecular 
identification lies in the fact that certain genomovars are 
associated with higher transmission and poor prognosis. [13] 
We have observed very little species-level diversity in our 
collection. This is an issue of concern that we have got 
Table 2: Antimicrobial susceptibility (Kirby-Bauer disc diffusion method) of 41 B. cepacia complex clinical isolates
Ceftazidime Co-trimoxazole Meropenem Piperacillin-
tazobactam
Tetracycline Levofloxacin
Sensitive 81.1 81.25 27.8 87.5 16.7 92.86
Resistant 10.81 18.75 72.22 9.38 77.78 7.14
Figure 3: (a and b) Bright yellow pigment is produced by the 
B. cepacia complex on iron-containing media [triple sugar iron agar 
(TSI) is shown in the figure]. Tubes A and B inoculated on the 20th 
December and the 18th December, and clicked on the 22nd December 
and the 20th December, respectively, i.e., pigment production is 
appreciable after 2 days of incubation of heavily inoculated TSI. (c) 
Stenotrophomonas maltophilia is H2S positive
Figure 2: (a) Polymerase chain reaction (PCR) of the recA gene. 
(b) Restriction fragment length polymorphism (RFLP) analysis of 
the recA PCR product. (a) Lane M, 50 bp molecular size marker; 
Lane 1, negative control; Lane 2, positive control; Lane 3, test strain 
(B. cepacia complex); Lane 4, Stenotrophomonas maltophilia. 
(b) RFLP type G is seen in lanes 1-3. The molecular size marker is 
shown in lane M (100-bp ladder)
a b
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the predominance of B. cenocepacia (genomovar IIIA; 
RFLP type G) that is associated with a high mortality rate. 
We have isolated this species from almost all the wards 
with predominance from ICU, paediatric ICU, paediatric 
emergency and bone marrow transplant units (data not 
shown), probably relating to its higher transmission rate.
Because of the high intrinsic resistance of the BCC 
to antimicrobial compounds, these infections can prove 
very difficult to treat and may be fatal.[17] Often reported 
as Pseudomonas species, the value of proper identification 
comes to the forefront. The antimicrobial susceptibility 
profile of our isolates reveals near-complete resistance to 
aminoglycosides, fluoroquinolones and more than 50% 
resistance to carbapenems, the first-line therapeutics of 
choice against serious pseudomonal infections. These 
isolates behaved similar to non-CF nosocomial Italian 
isolates by showing susceptibility to ceftazidime.[18] As 
per the CLSI guidelines, the drugs recommended against 
BCC are ceftazidime, minocycline, meropenem and co-
trimoxazole, and minocycline, levofloxacin and ceftazidime 
are recommended against S. maltophilia.[12] A microbiologist 
or trained technician can suspect these NFGNBs, noting 
the different colony morphology and odour (from P. 
aeruginosa) on the first isolation. Then he/she can put up 
the sensitivity against five of the common drugs for these 
lysine-positive NFGNBs on a single sensitivity plate.
Although a ubiquitous organism, isolates of BCC do 
not survive long on culture plates. The BCC grows well 
on most laboratory media but may lose viability on blood 
agar in 3-4 days.[19] Maintenance in RCM is very useful for 
early and easy revival of these organisms. These organisms 
survived for a minimum of 14 days, which helped us in 
working with them. The RCM preservation method is yet to 
be standardized in a proper manner as performed for Vibrio 
cholerae isolates.[20] One can inoculate the strain in RCM 
and carry on the identification as decarboxylases have to be 
kept for 5-7 days before reporting as negative. However, the 
decarboxylases give a positive result by the next day if minor 
modifications are made. Inoculate with a heavy inoculum 
of 0.5 mL of the decarboxylase medium (properly adjusted 
pH) and then add liquid paraffin to it. In addition, a bright 
yellow pigment is produced by the BCC on iron-containing 
media (like triple sugar iron agar, heavily inoculated), which 
becomes more prominent after 2-3 days of incubation.
The BCC does not survive in nutrient stab agars. If 
we need to transport these organisms, it can be carried 
out on nutrient agar slants. We have already tested our 
10% brain heart infusion-glycerol broths stored at −20°C 
(−80°C is better) and lyophilized ampoules (best method 
of preservation) to find these organisms viable after 4 years 
(longer period revival is yet to be carried out). Lyophilization 
technique is considered the gold standard for long-term 
preservation of bacteria and fungi.[8] The technique retains 
its extreme usefulness even in gram-negative bacteria like 
the NFGNBs, in spite of a slight fall in viability.
It can be concluded that BCC and S. maltophilia can 
be identified with relative ease using a small battery of 
biochemical reactions. Use of simplified methods will allow 
greater recognition of their pathogenic potential and correct 
antimicrobial advice in other clinical laboratories and 
hospitals.
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